Corneal and External Eye Disease Service, Singapore National Eye Center, Singapore, Singapore.
Ocular Surface Research Group, Singapore Eye Research Institute, Singapore, Singapore.
Ocul Immunol Inflamm. 2021 Nov 17;29(7-8):1606-1615. doi: 10.1080/09273948.2020.1757121. Epub 2020 May 29.
: There are no clinical studies directly comparing anionic and cationic emulsions of cyclosporine for the treatment of dry eye disease (DED). We therefore conducted a literature review to evaluate the efficacy and safety of these different formulations.: A literature search was performed in Embase and Medline from January 1999 to May 2019 to identify publications that evaluated clinical outcomes with either cyclosporine anionic or cationic emulsion in patients with moderate-to-severe or severe DED.: Thirteen publications met criteria. In patients with moderate-to-severe disease, evidence demonstrated improvement in the signs of DED with both formulations. However, improvement in symptoms was not consistently demonstrated. Studies specifically in severe DED were only identified with the cationic emulsion and showed improvement in the objective signs of DED. There were no obvious differences in tolerability between products.: Both formulations are effective for the treatment of moderate-to-severe DED and are well tolerated.
: 目前尚无直接比较环孢素阴离子和阳离子乳剂治疗干眼疾病 (DED) 的临床研究。因此,我们进行了文献回顾,以评估这些不同配方的疗效和安全性。: 从 1999 年 1 月至 2019 年 5 月,在 Embase 和 Medline 中进行了文献检索,以确定评估中重度或重度 DED 患者使用环孢素阴离子或阳离子乳剂的临床结果的出版物。: 有 13 篇出版物符合标准。在中重度疾病患者中,两种制剂均能改善 DED 的体征。然而,症状的改善并不一致。仅在严重 DED 患者中进行的研究才发现阳离子乳剂,并且 DED 的客观体征有所改善。产品之间的耐受性没有明显差异。: 两种制剂均能有效治疗中重度 DED,且耐受性良好。